1. In this systematic review, low-strength evidence suggests that increased fluid intake, dietary modification (normal-to-high calcium, low protein, low sodium), ...
1. Over a one-year period, the incidence of recurrent gout flares in patients with gout and diabetes was significantly lower ...
1. The composite score for non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death was comparable between allopurinol (11.0%) and usual ...
1. In patients with gout and chronic kidney disease, the initiation of allopurinol was not associated with increased mortality. 2. ...
1. Febuxostat was non-inferior to allopurinol for primary cardiovascular endpoints including hospitalization for non-fatal myocardial infarction or biomarker-positive acute coronary ...
1. Serum urate reduction with allopurinol was not shown to clinically benefit kidney function among patients with type 1 diabetes ...
